B3GNT3 antibody 18098-1-AP from Proteintech Group Inc | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
Proteintech Group Inc for
B3GNT3 antibody

Description

The B3GNT3 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of B3GNT3. This antibody recognizes recombinant protein antigen. The B3GNT3 antibody has been validated for the following applications: WB, IHC, ELISA analysis

Product Specs
ItemB3GNT3 antibody
CompanyProteintech Group Inc
Price Pricing Info Supplier Page View Company Product Page
Catalog Number18098-1-AP
Antibody Typeprimary antibodies
ClonalityPolyclonal
ReactivityHuman, Mouse
FormatPBS with 0.02% sodium azide and 50% glycerol pH 7.3
ApplicationsWB, IHC, ELISA
IsotypeIgG
Quantity150ul
ImmunogenRecombinant protein
TargetB3GNT3
Conjugate/TagUnconjugated
HostRabbit
PurityAntigen affinity purification
NCBI Full Gene NameUDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3
NCBI Gene AliasesB3GAL-T8, B3GN-T3, B3GNT-3, HP10328, TMEM3, beta3Gn-T3

Add to Compare List

Proteintech Group Inc

Proteintech Group Inc

5500 Pearl Street, Suite 400

Rosemont,, Illinois 60018

United States

Phone: 1-888-478-4522

Email: proteintech@ptglab.com

Company Profile

Website: http://www.ptglab.com

(1) A novel glycosylation-related gene signature predicts survival in patients with lung adenocarcinomaBMC bioinformaticsDecember 27, 2022Liang JX, Chen Q, Gao W, Chen D, Qian XY, Bi JQ, Lin XC, Han BB, Liu JS.

(2) Identifying the prognostic significance of B3GNT3 with PD-L1 expression in lung adenocarcinomaTranslational lung cancer researchFebruary 1, 2021Leng X, Wei S, Mei J, Deng S, Yang Z, Liu Z, Guo C, Deng Y, Xia L, Cheng J, et al.

(3) B3GNT3: A prognostic biomarker associated with immune cell infiltration in pancreatic adenocarcinomaOncology lettersFebruary 1, 2021Kong K, Zhao Y, Xia L, Jiang H, Xu M, Zheng J.

(4) B3GNT3 overexpression is associated with unfavourable survival in non-small cell lung cancerJournal of clinical pathologyJuly 1, 2018Gao L, Zhang H, Zhang B, Zhu J, Chen C, Liu W.

(5) Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1Cancer cellFebruary 12, 2018Li CW, Lim SO, Chung EM, Kim YS, Park AH, Yao J, Cha JH, Xia W, Chan LC, Kim T, et al.

(6) B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical CancerPloS oneJanuary 1, 2015Zhang W, Hou T, Niu C, Song L, Zhang Y.

Be the First to Write a Review!